223 related articles for article (PubMed ID: 10870645)
1. Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Cervello M; Virruso L; Lipani G; Giannitrapani L; Soresi M; Carroccio A; Gambino R; Sanfililippo R; Marasà L; Montalto G
J Cancer Res Clin Oncol; 2000 Jun; 126(6):345-51. PubMed ID: 10870645
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
Kitaoka S; Shiota G; Kawasaki H
Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
[TBL] [Abstract][Full Text] [Related]
3. Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma.
Moussa YI; Plevris JN; Hayes PC
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):159-63. PubMed ID: 10741929
[TBL] [Abstract][Full Text] [Related]
4. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
Van Tong H; Van Ba N; Hoan NX; Binh MT; Quyen DT; Son HA; Van Luong H; Quyet D; Meyer CG; Song LH; Toan NL; Velavan TP
BMC Infect Dis; 2018 Nov; 18(1):553. PubMed ID: 30419833
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
[TBL] [Abstract][Full Text] [Related]
7. Circulating intercellular adhesion molecule-1 in chronic liver disease and hepatocellular carcinoma.
Huang YS; Wu JC; Chan CY; Chao Y; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):487-95. PubMed ID: 10462824
[TBL] [Abstract][Full Text] [Related]
8. [Fluorescence of age in serum in detecting liver cirrhosis and hepatocellular carcinoma among patients with anti-HCV antibodies].
Górka J; Zuwała-Jagiełło J; Pazgan-Simon M; Simon K; Warwas M
Przegl Epidemiol; 2008; 62(2):393-400. PubMed ID: 18807486
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma.
El-Shal AS; Zidan HE; Rashad NM; Wadea FM
Cytokine; 2017 Aug; 96():75-86. PubMed ID: 28371666
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Ornithine Carbamoyltransferase in the Progression of Chronic Hepatitis C and Liver Cirrhosis.
Ohnishi M; Higuchi A; Matsumura H; Arakawa Y; Nakamura H; Nirei K; Yamamoto T; Yamagami H; Ogawa M; Gotoda T; Matsuoka S; Nakajima N; Sugitani M; Moriyama M; Murayama H
Int J Med Sci; 2017; 14(7):629-638. PubMed ID: 28824294
[No Abstract] [Full Text] [Related]
11. Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma.
Soresi M; Cervello M; Lipani G; Carroccio A; Cartabellotta A; Marasà L; Casto C; Virruso L; Montalto G
Eur J Gastroenterol Hepatol; 1997 Aug; 9(8):805-9. PubMed ID: 9282280
[TBL] [Abstract][Full Text] [Related]
12. A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels.
Nakayama A; Fukuda H; Ebara M; Hamasaki H; Nakajima K; Sakurai H
Biol Pharm Bull; 2002 Apr; 25(4):426-31. PubMed ID: 11995918
[TBL] [Abstract][Full Text] [Related]
13. Circulating E-selectin levels in chronic hepatitis C patients with normal or elevated transaminase before and after alpha-interferon treatment.
Montalto G; Giannitrapani L; Soresi M; Virruso L; Martino DD; Gambino R; Carroccio A; Cervello M
Inflammation; 2001 Apr; 25(2):101-8. PubMed ID: 11321356
[TBL] [Abstract][Full Text] [Related]
14. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
[TBL] [Abstract][Full Text] [Related]
15. Selenium levels in patients with hepatitis C virus-related chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma: a pilot study.
Bettinger D; Schultheiss M; Hennecke N; Panther E; Knüppel E; Blum HE; Thimme R; Spangenberg HC
Hepatology; 2013 Jun; 57(6):2543-4. PubMed ID: 23172787
[No Abstract] [Full Text] [Related]
16. Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C.
Ferri S; Lalanne C; Lanzoni G; Bassi M; Asioli S; Cipriano V; Pappas G; Muratori P; Lenzi M; Muratori L
Dig Liver Dis; 2011 Oct; 43(10):807-13. PubMed ID: 21684822
[TBL] [Abstract][Full Text] [Related]
17. Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases.
Miyakawa H; Kikazawa E; Abe K; Kikuchi K; Fujikawa H; Matsushita M; Kawaguchi N; Morizane T; Ohya K; Kako M
Autoimmunity; 1999; 30(2):107-14. PubMed ID: 10435724
[TBL] [Abstract][Full Text] [Related]
18. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
[TBL] [Abstract][Full Text] [Related]
19. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection.
Sumida Y; Nakashima T; Yoh T; Nakajima Y; Ishikawa H; Mitsuyoshi H; Sakamoto Y; Okanoue T; Kashima K; Nakamura H; Yodoi J
J Hepatol; 2000 Oct; 33(4):616-22. PubMed ID: 11059866
[TBL] [Abstract][Full Text] [Related]
20. Cancer biomarker profiling in patients with chronic hepatitis C virus, liver cirrhosis and hepatocellular carcinoma.
Costantini S; Capone F; Maio P; Guerriero E; Colonna G; Izzo F; Castello G
Oncol Rep; 2013 Jun; 29(6):2163-8. PubMed ID: 23564159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
